Bio-Rad Laboratories Overview

  • Year Founded
  • 1952

Year Founded

  • Status
  • Public

  • Employees
  • 8,030

Employees

  • Stock Symbol
  • BIO

Stock Symbol

  • Investments
  • 33

  • Share Price
  • $342.13
  • (As of Friday Closing)

Bio-Rad Laboratories General Information

Description

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Contact Information

Website
www.bio-rad.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 1000 Alfred Nobel Drive
  • Hercules, CA 94547
  • United States
+1 (510)
Primary Industry
Diagnostic Equipment
Stock Exchange
NYS
Vertical(s)
FoodTech, Life Sciences
Corporate Office
  • 1000 Alfred Nobel Drive
  • Hercules, CA 94547
  • United States
+1 (510)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bio-Rad Laboratories Stock Performance

As of 07-Feb-2025, Bio-Rad Laboratories’s stock price is $342.13. Its current market cap is $9.6B with 28M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$342.13 $345.41 $262.12 - $387.99 $9.6B 28M 174K -$27.74

Bio-Rad Laboratories Financials Summary

As of 30-Sep-2024, Bio-Rad Laboratories has a trailing 12-month revenue of $2.58B.

In Thousands,
USD
TTM 30-Sep-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 9,061,734 9,045,770 11,989,245 21,327,419
Revenue 2,580,209 2,671,262 2,802,249 2,922,545
EBITDA (889,415) (755,665) (4,586,859) 5,569,306
Net Income (778,690) (637,324) (3,627,535) 4,254,257
Total Assets 10,603,472 12,299,070 13,501,666 17,799,393
Total Debt 1,388,115 1,405,443 1,388,098 223,376
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bio-Rad Laboratories Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bio-Rad Laboratories‘s full profile, request access.

Request a free trial

Bio-Rad Laboratories Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions fo
Diagnostic Equipment
Hercules, CA
8,030 As of 2023

San Diego, CA
 

Kobe, Japan
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bio-Rad Laboratories Competitors (20)

One of Bio-Rad Laboratories’s 20 competitors is Illumina, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Illumina Formerly VC-backed San Diego, CA
Sysmex (Diagnostic Equipment) Corporation Kobe, Japan
QuidelOrtho Corporation San Diego, CA
BioMérieux (Diagnostic Equipment) Formerly PE-Backed Marcy-l'Etoile, France
AliveDx Formerly VC-backed Eysins, Switzerland
You’re viewing 5 of 20 competitors. Get the full list »

Bio-Rad Laboratories Patents

Bio-Rad Laboratories Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250043362-A1 Selective digital multiplexing Pending 04-Aug-2023
US-20240384335-A1 Linkage assay Pending 19-May-2023
US-20240367161-A1 Multimodal chromatography resins with anionic and cationic ligands Pending 05-May-2023
US-20240367143-A1 Polymer-hydroxyapatite composite membranes Pending 02-May-2023
US-20240367141-A1 Particulate hydroxyapatite (ha) substrates and uses thereof Pending 02-May-2023 B01J20/282
To view Bio-Rad Laboratories’s complete patent history, request access »

Bio-Rad Laboratories Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bio-Rad Laboratories Investments & Acquisitions (33)

Bio-Rad Laboratories’s most recent deal was a Later Stage VC with Geneoscopy for . The deal was made on 08-Jan-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Geneoscopy 08-Jan-2025 Later Stage VC Diagnostic Equipment
OncoCyte 02-Oct-2024 PIPE Diagnostic Equipment
Genetic Analysis 01-Jul-2024 PIPE Laboratory Services (Healthcare)
OncoCyte 15-Apr-2024 PIPE Diagnostic Equipment
Curiosity Diagnostics 03-Aug-2022 Merger/Acquisition Diagnostic Equipment
You’re viewing 5 of 33 investments and acquisitions. Get the full list »

Bio-Rad Laboratories ESG

Risk Overview

Risk Rating

Updated May, 31, 2024

16.77 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 15,120

Rank

Percentile

Pharmaceuticals

Industry

of 853

Rank

Percentile

Laboratory Equipment and Services

Subindustry

of 60

Rank

Percentile

To view Bio-Rad Laboratories’s complete esg history, request access »

Bio-Rad Laboratories Exits (2)

Bio-Rad Laboratories’s most recent exit was on 01-Feb-2017 from Propel Labs (Flow cytometry Platform). The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Propel Labs (Flow cytometry Platform) 01-Feb-2017 Completed
Cellular Life Sciences 01-Jan-1970 Merger/Acquisition Completed
To view Bio-Rad Laboratories’s complete exits history, request access »

Affiliates

Subsidiaries (4)

Name Industry Location Year Founded
ODx Inverness, United Kingdom 2016
Exact Diagnostics Fort Worth, TX 2015
GnuBIO Cambridge, MA 2009
Bio-Rad Antibodies Kidlington, United Kingdom 1952

Bio-Rad Laboratories FAQs

  • When was Bio-Rad Laboratories founded?

    Bio-Rad Laboratories was founded in 1952.

  • Where is Bio-Rad Laboratories headquartered?

    Bio-Rad Laboratories is headquartered in Hercules, CA.

  • What is the size of Bio-Rad Laboratories?

    Bio-Rad Laboratories has 8,030 total employees.

  • What industry is Bio-Rad Laboratories in?

    Bio-Rad Laboratories’s primary industry is Diagnostic Equipment.

  • Is Bio-Rad Laboratories a private or public company?

    Bio-Rad Laboratories is a Public company.

  • What is Bio-Rad Laboratories’s stock symbol?

    The ticker symbol for Bio-Rad Laboratories is BIO.

  • What is the current stock price of Bio-Rad Laboratories?

    As of 07-Feb-2025 the stock price of Bio-Rad Laboratories is $342.13.

  • What is the current market cap of Bio-Rad Laboratories?

    The current market capitalization of Bio-Rad Laboratories is $9.6B.

  • What is Bio-Rad Laboratories’s current revenue?

    The trailing twelve month revenue for Bio-Rad Laboratories is $2.58B.

  • Who are Bio-Rad Laboratories’s competitors?

    Illumina, Sysmex (Diagnostic Equipment), QuidelOrtho, BioMérieux (Diagnostic Equipment), and AliveDx are some of the 20 competitors of Bio-Rad Laboratories.

  • What is Bio-Rad Laboratories’s annual earnings per share (EPS)?

    Bio-Rad Laboratories’s EPS for 12 months was -$27.74.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »